I first met Barrie, not long after I joined Neuroendocrine Cancer UK, about 7 years ago, at a Natter group: one he co-founded and facilitated in Letchworth Garden City. He’d been diagnosed with Neuroendocrine Cancer in 2008, and first became aware of and involved with...
There is a voiced genuine concern regarding the huge impact the Covid-19 Pandemic has had, and will have, on healthcare for patients with cancer. To understand the impact this has had on the Neuroendocrine Cancer Community, a group often thought of as more...
The UK Government has set out a roadmap for the clinically extremely vulnerable on the future of the shielding programme. For now, the guidance remains the same – stay at home and only go outside to exercise or to spend time outdoors with a member of your household,...
Mylan is experiencing a temporary supply constraint of Creon 25K. AAH, Alliance & Phoenix wholesalers last received stock of the 25k, 16th and 17th June 2020, varying by depot. Pharmacies should contact their preferred wholesaler for availability, although, we...
ENETS will host a series of conversations with NET experts in two separate webinars on 11 June 2020. In these webinars, we will interview a panel of NET experts from high-volume Covid areas. The webinars will enable NET physicians to share their experiences and learn...
Neuroendocrine neoplasia is described in almost every tissue, either in the pure endocrine organs, the nerve structures or in the so-called diffuse neuroendocrine system. The current nomenclature contains time-honored, widely accepted definitions; however, it is...
